U.S. Markets closed

GSK hikes price of subsidiary Tesaro's ovarian cancer drug

Allison DeAngelis
GSK hikes price of subsidiary Tesaro's ovarian cancer drug

Drug giant GlaxoSmithKline raised the price of cancer drug Zejula by 5 percent this week, bringing the cost for a 30-day supply of 100 milligram Zejula tablets from $6,567 to $6,913.